Source: Virtual Congress 2021 – Respiratory infections and bronchiectasis outcomes



Rating:

Share or cite this content

Citations should be made in the following way:
R. Dhar (West Bengal, India), S. Singh (Jaipur, India), D. Talwar (India, India), M. Mohan (Karnataka, India), S. Tripathi (Utter Pradesh, India), R. Swarnakar (Nagpur, India), S. Trivedi (Chhattisgarh, India), S. Rajagopala (Tamil Nadu, India), G. D'Souza (Karnataka, India), A. Padmanabhan ( Kerala, India), A. Baburao (Karnataka, India), P. Goeminne (Nikolaas, Belgium), M. Crichton (Dundee, United Kingdom), J. Chalmers (Dundee, United Kingdom), S. Limaye (Pune, India), S. Salvi (Pune, India). Long term clinical outcomes of bronchiectasis in India: Data from the EMBARC/RRNI Indian Bronchiectasis Registry. 2855

Member's Comments

No comment yet.

Related content which might interest you: Post-Tuberculosis Bronchiectasis in India:Outcomes of the Indian EMBARC Registry Source: International Congress 2018 – Pulmonary tuberculosis: long term complications, rehabilitation and challenges Year: 2018 Heterogeneity in bronchiectasis service provision in Europe: Baseline data from the European bronchiectasis registry (EMBARC) Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook Year: 2015 Management of bronchiectasis in Europe: Data from the European bronchiectasis registry (EMBARC) Source: International Congress 2016 – Clinical update on bronchiectasis Year: 2016 Asthma as a co-morbidity and cause of bronchiectasis: data from the European Bronchiectasis Registry (EMBARC). Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis Year: 2020 Late-breaking abstract: Demographic trends and changes In long term outcome of incident idiopathic, heritable and anorexigen-associated pulmonary arterial hypertension between 2001 to 2009. Results from the Pulmonary Hypertension Registry of the United Kingdom and Ireland Source: Annual Congress 2011 - Clinical features of human pulmonary hypertension Year: 2011 Treatment of patients with idiopathic pulmonary fibrosis in real-life setting: Results from the Latin American Pulmonary Fibrosis Registry REFIPI Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis Year: 2019 The management of non-CF bronchiectasis in Europe: data from the European Bronchiectasis Network Source: International Congress 2015 – Bronchiectasis in Europe: an update from the European Bronchiectasis Network (EMBARC) Year: 2015 Clinico-pathological profile of adult bronchiectasis patients at a North Indian teaching hospital Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections Year: 2016 Impact of bronchiectasis on severe asthma: data from the “Severe Asthma Network Italy” (SANI) registry Source: International Congress 2018 – Determinants and monitoring of asthma control Year: 2018 Late Breaking Abstract - Preliminary analysis of the data of patients with severe bronchial asthma included in the Russian National Register of Severe Asthma (RSAR) Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts Year: 2019 COVID-19 and biologics in severe asthma: data from the Belgian Severe Asthma Registry Source: Eur Respir J, 56 (6) 2002857; 10.1183/13993003.02857-2020 Year: 2020 Primary care management of asthma in Malaysia: findings of the Klang Asthma Cohort Study Source: Virtual Congress 2020 – Organising respiratory disease management in primary care Year: 2020 Phenotypes in Bronchiectasis from the EMBARC India Registry Source: International Congress 2018 – Bronchiectasis: phenotypes, endotypes and new therapies Year: 2018 The heterogeneity of bronchiectasis patient characteristics, management and outcomes across Europe: Data from the EMBARC registry Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis Year: 2018 Late-breaking abstract: Short term improvement in 6 minute walk distance predicts long term survival in incident idiopathic pulmonary arterial hypertension. Results from the Pulmonary Hypertension Registry of the United Kingdom and Ireland Source: Annual Congress 2011 - Treatment of pulmonary hypertension Year: 2011 Bronchiectasis severity assessment tools to predict clinical outcomes in the Indian Bronchiectasis Registry Source: Virtual Congress 2021 – Bronchiectasis and pleural infection Year: 2021 Incidence and remission of asthma in adults: results from the West Sweden Asthma Study Source: International Congress 2018 – Asthma and allergy in adults and children and their biomarkers Year: 2018 Validation of short- and long-term demographic forecasts using the Canadian Cystic Fibrosis Registry Source: Eur Respir J, 55 (1) 1901667; 10.1183/13993003.01667-2019 Year: 2020 Performance of immune-based and microbiological tests in children with tuberculosis meningitis in Europe: a multicentre Paediatric Tuberculosis Network European Trials Group (ptbnet) study Source: Eur Respir J, 56 (1) 1902004; 10.1183/13993003.02004-2019 Year: 2020 Proportion of complete responders after one year of treatment with biologics for severe asthma - Results from the nationwide Danish Severe Asthma Register. Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases Year: 2020